EULAV Asset Management Sells 6,600 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

EULAV Asset Management trimmed its position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 25.7% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 19,100 shares of the company's stock after selling 6,600 shares during the period. EULAV Asset Management owned approximately 0.13% of U.S. Physical Therapy worth $1,382,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the company. CBIZ Investment Advisory Services LLC lifted its position in U.S. Physical Therapy by 59.8% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock worth $29,000 after buying an additional 122 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new stake in U.S. Physical Therapy during the fourth quarter worth about $39,000. Fifth Third Bancorp boosted its position in U.S. Physical Therapy by 34.6% during the first quarter. Fifth Third Bancorp now owns 1,030 shares of the company's stock valued at $75,000 after purchasing an additional 265 shares during the last quarter. Lazard Asset Management LLC bought a new position in U.S. Physical Therapy in the fourth quarter valued at approximately $84,000. Finally, Aquatic Capital Management LLC grew its stake in U.S. Physical Therapy by 18.0% in the fourth quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock valued at $115,000 after purchasing an additional 198 shares in the last quarter.

U.S. Physical Therapy Stock Up 1.8%

Shares of NYSE:USPH opened at $82.14 on Monday. The firm has a market cap of $1.25 billion, a P/E ratio of 37.68, a P/E/G ratio of 3.98 and a beta of 1.44. U.S. Physical Therapy, Inc. has a 12-month low of $62.77 and a 12-month high of $101.20. The business has a fifty day simple moving average of $76.11 and a 200 day simple moving average of $79.41. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.32.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.02. U.S. Physical Therapy had a net margin of 4.57% and a return on equity of 7.89%. The company had revenue of $183.79 million during the quarter, compared to analysts' expectations of $176.78 million. During the same period in the prior year, the company posted $0.51 earnings per share. U.S. Physical Therapy's revenue for the quarter was up 18.0% compared to the same quarter last year. Analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, June 13th. Investors of record on Friday, May 23rd were given a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a yield of 2.19%. The ex-dividend date was Friday, May 23rd. U.S. Physical Therapy's payout ratio is currently 82.57%.

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. JPMorgan Chase & Co. decreased their price objective on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Wednesday, March 19th. Wall Street Zen upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Thursday, May 8th. JMP Securities reissued a "market outperform" rating and set a $113.00 price target on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $98.00 price objective on shares of U.S. Physical Therapy in a research report on Tuesday, July 1st. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $109.00.

Insiders Place Their Bets

In other news, Director Nancy Ham sold 400 shares of the stock in a transaction dated Thursday, June 12th. The shares were sold at an average price of $78.01, for a total value of $31,204.00. Following the completion of the sale, the director owned 2,594 shares in the company, valued at $202,357.94. This represents a 13.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 2.00% of the company's stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.